Cannabis Re-Classification
23 Jan 2004
Statement by Multiple Sclerosis Society
Mike O'Donovan, chief executive of the Multiple Sclerosis Society, said, The Society does not encourage the smoking of cannabis but we have consistently urged the courts to deal sympathetically with people with MS who use it to seek relief from symptoms like pain, spasticity and bladder problems.
Our main concern, however, is to see cannabis-derived medicines available on the NHS. Two clinical trials of these drugs have been completed. On the evidence now available, we believe those who might benefit should be able to have treatment prescribed. We also want to see further research into such medicines vigorously pursued.










